2017 NCI IMAT PI Meeting header


As an IMAT PI, you and your team members are invited to attend the National Cancer Institute's Innovative Molecular Analysis Technologies (IMAT) Principal Investigators Meeting to be held December 6-8, 2017, at the new NCI at Shady Grove building in Rockville, MD. There is no registration fee to attend, but all other expenses, including travel, lodging and meals/refreshments, are the responsibility of each participant.

Since 1998, the IMAT program (http://innovation.cancer.gov) has been a key component of NCI’s strategy for supporting innovative and emerging technologies for cancer research and clinical care and your involvement as a grantee is important. This annual meeting is organized to address two important aims of the IMAT program:

  • Provide NCI program staff a chance to interact directly with PIs and receive an update on progress to date of supported research

  • Present opportunities for interactions and exchanges of ideas among meeting participants, which is critical to sparking potentially transformative project collaborations, receiving critical feedback and guidance from the community, and fostering dissemination of the exciting technologies emerging from IMAT-supported researchers.

There are always more exciting active research projects in the IMAT portfolio than we have timeslots to accommodate at the meeting. As has been done for prior years, podium presentation slots will be prioritized for projects nearing the end of their IMAT award period and projects fitting selected themes followed by those indicating noteworthy progress. We will continue the short "Poster Highlights" presentations to further capture selected investigators with significant progress to report involving very short overview talks on their research, noting that more detailed information may be gleaned from their posters.

On behalf of the NCI program staff and everyone involved in the planning for this meeting, I thank you for your participation, your interest, and the important work you all do to assist in our collective mission against cancer. I look forward to an exciting and productive meeting.

Kind Regards,

Tony Dickherber, Ph.D.
Program Director, IMAT

Center for Strategic Scientific Initiatives
National Cancer Institute, National Institutes of Health
U.S. Department of Health & Human Services



Contact Us

For agenda, presentations

and poster questions:

Tony Dickherber
IMAT Program Director

For registration and

lodging questions:

Kathleen Berry
Infinity Conference Group
703-925-9455, ext. 119